Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain Journal Article


Authors: Ferri, A. L. M.; Cavallaro, M.; Braida, D.; Di Cristofano, A.; Canta, A.; Vezzani, A.; Ottolenghi, S.; Pandolfi, P. P.; Sala, M.; DeBiasi, S.; Nicolis, S. K.
Article Title: Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain
Abstract: In many species, the Sox2 transcription factor is a marker of the nervous system from the beginning of its development, and we have previously shown that Sox2 is expressed in embryonic neural stem cells. It is also expressed in, and is essential for, totipotent inner cell mass stem cells and other multipotent cell lineages, and its ablation causes early embryonic lethality. To investigate the role of Sox2 in the nervous system, we generated different mouse mutant alleles: a null allele (Sox2β-geo 'knock-in'), and a regulatory mutant allele (Sox2ΔENH), in which a neural cell-specific enhancer is deleted. Sox2 is expressed in embryonic early neural precursors of the ventricular zone and, in the adult, in ependyma (a descendant of the ventricular zone). It is also expressed in the vast majority of dividing precursors in the neurogenic regions, and in a small proportion of differentiated neurones, particularly in the thalamus, striatum and septum. Compound Sox2β-geo/ΔENH heterozygotes show important cerebral malformations, with parenchymal loss and ventricle enlargement, and L-dopa-rescuable circling behaviour and epilepsy. We observed striking abnormalities in neurones; degeneration and cytoplasmic protein aggregates, a feature common to diverse human neurodegenerative diseases, are observed in thalamus, striatum and septum. Furthermore, ependymal cells show ciliary loss and pathological lipid inclusions. Finally, precursor cell proliferation and the generation of new neurones in adult neurogenic regions are greatly decreased, and GFAP/nestin-positive hippocampal cells, which include the earliest neurogenic precursors, are strikingly diminished. These findings highlight a crucial and unexpected role for Sox2 in the maintenance of neurones in selected brain areas, and suggest a contribution of neural cell proliferative defects to the pathological phenotype.
Keywords: controlled study; protein expression; unclassified drug; gene deletion; mutation; dna-binding proteins; nonhuman; protein function; cell proliferation; animal cell; mouse; mouse mutant; mammalia; animals; mice; allele; animal tissue; cell survival; embryo; lipid; animal experiment; animal model; alleles; transcription factor; neurons; heterozygote; cell specificity; animalia; mice, transgenic; transcription factors; stem cell; nuclear proteins; in situ hybridization; gene expression regulation, developmental; brain; brain disease; protein deficiency; epilepsy; neurologic disease; neural stem cells; nerve cell differentiation; nestin; neurogenesis; sox2; transcription factor sox2; brain malformation; corpus striatum; embryo cell; electroencephalography; behavior, animal; nerve degeneration; neurodegeneration; nervous system; neurodegenerative diseases; enhancer region; hippocampus; protein aggregation; thalamus; brain ventricle dilatation; levodopa; septum pellucidum; cytoplasm protein; cell loss; ependyma cell; hmgb proteins; humans; female; priority journal; article; hippocampal precursors; neuronal inclusions; circling behavior; culture techniques
Journal Title: Development
Volume: 131
Issue: 15
ISSN: 0950-1991
Publisher: Company of Biologists  
Date Published: 2004-08-01
Start Page: 3805
End Page: 3819
Language: English
DOI: 10.1242/dev.01204
PROVIDER: scopus
PUBMED: 15240551
DOI/URL:
Notes: Development (Cambridge) -- Cited By (since 1996):273 -- Export Date: 16 June 2014 -- CODEN: DEVPE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors